Delforterie M J, Lynskey M T, Huizink A C, Creemers H E, Grant J D, Few L R, Glowinski A L, Statham D J, Trull T J, Bucholz K K, Madden P A F, Martin N G, Heath A C, Agrawal A
VU University, Department of Developmental Psychology and EMGO Institute for Health and Care Research, Amsterdam, The Netherlands.
Addictions Department, Institute of Psychiatry, King's College London, United Kingdom.
Drug Alcohol Depend. 2015 May 1;150:98-104. doi: 10.1016/j.drugalcdep.2015.02.019. Epub 2015 Feb 26.
In the present study, we examined the relationship between cannabis involvement and suicidal ideation (SI), plan and attempt, differentiating the latter into planned and unplanned attempt, taking into account other substance involvement and psychopathology.
We used two community-based twin samples from the Australian Twin Registry, including 9583 individuals (58.5% female, aged between 27 and 40). The Semi-Structured Assessment of the Genetics of Alcoholism (SSAGA) was used to assess cannabis involvement which was categorized into: (0) no cannabis use (reference category); (1) cannabis use only; (2) 1-2 cannabis use disorder symptoms; (3) 3 or more symptoms. Separate multinomial logistic regression analyses were conducted for SI and suicide attempt with or without a plan. Twin analyses examined the genetic overlap between cannabis involvement and SI.
All levels of cannabis involvement were related to SI, regardless of duration (odds ratios [ORs]=1.28-2.00, p<0.01). Cannabis use and endorsing ≥3 symptoms were associated with unplanned (SANP; ORs=1.95 and 2.51 respectively, p<0.05), but not planned suicide attempts (p>0.10). Associations persisted even after controlling for other psychiatric disorders and substance involvement. Overlapping genetic (rG=0.45) and environmental (rE=0.21) factors were responsible for the covariance between cannabis involvement and SI.
Cannabis involvement is associated, albeit modestly, with SI and unplanned suicide attempts. Such attempts are difficult to prevent and their association with cannabis use and cannabis use disorder symptoms requires further study, including in different samples and with additional attention to confounders.
在本研究中,我们考察了大麻使用与自杀意念(SI)、自杀计划及自杀未遂之间的关系,将自杀未遂分为有计划和无计划的自杀未遂,并考虑了其他物质使用情况和精神病理学因素。
我们使用了来自澳大利亚双胞胎登记处的两个基于社区的双胞胎样本,共9583人(女性占58.5%,年龄在27至40岁之间)。使用酒精中毒遗传学半结构化评估(SSAGA)来评估大麻使用情况,分为:(0)未使用大麻(参照类别);(1)仅使用大麻;(2)有1 - 2个大麻使用障碍症状;(3)有3个或更多症状。对有或无计划的SI和自杀未遂分别进行多项逻辑回归分析。双胞胎分析考察了大麻使用与SI之间的遗传重叠情况。
无论使用时长如何,所有大麻使用水平均与SI相关(优势比[ORs]=1.28 - 2.00,p<0.01)。使用大麻及有≥3个症状与无计划自杀未遂相关(分别为ORs=1.95和2.51,p<0.05),但与有计划自杀未遂无关(p>0.10)。即使在控制了其他精神障碍和物质使用情况后,这种关联仍然存在。重叠的遗传因素(rG=0.45)和环境因素(rE=0.21)导致了大麻使用与SI之间的协方差。
大麻使用与SI及无计划自杀未遂存在关联,尽管关联程度不大。此类自杀未遂难以预防,其与大麻使用及大麻使用障碍症状之间的关联需要进一步研究,包括在不同样本中进行研究,并更多地关注混杂因素。